Search CommunityWalk:


Profectus BioSciences, Inc.

6411 Beckley Street
Baltimore, MD, USA

Category: Drug Delivery

Used in the following map:

Maryland Biotech Industry Map

Profectus BioSciences, Inc. is a research and development company engaged in advancing the treatment and prevention of chronic infectious diseases. It was established in 2003 with a vision to reduce morbidity and mortality by advancing technologies and developing products that can be used to treat and prevent viral diseases. The company's mission is to "do well by doing good" for humankind and deliver superior returns to its shareholders.

Profectus' discovery and development programs include Therapeutic vaccination and Immunotherapeutics. Its therapeutic vaccination program focused on Hepatitis C Virus (HCV), Human Papilloma Virus (HPV), Herpes Simplex Virus type 2 (HSV-2), and Human Immunodeficiency Virus (HIV).

Profectus has designed multi-pronged approaches to identify inhibitors of NF-kB a focus on inhibiting the p65, a key regulator of immune activated genes. The company has in-licensed two powerful vaccine delivery platforms that can be used either alone or in combination to improve therapeutic outcomes. Its vaccine products include pDNA Vaccines, Vesicular stomatitis virus (rVSV) Vectored Vaccines, Transition-State Vaccines, Genetic Adjuvants and Thermal Stabilizers.

Profectus BioSciences has received 2009 best of baltimore award and 2006 technology transfer company of the Year. The company's partners include: Ichor Medical Systems, Inc, National Institute of Allergy and Infectious Diseases, National Institutes of Health, PATH (Program for Appropriate Technology in Health), PATH Malaria Vaccine Initiative, The National Cancer Institute, The U.S. Department of Health and Human Services, Wyeth (formerly American Home Products Corporation) and Wyeth Pharmaceuticals.